About

Ms. Miyashita is an independent member of Halozyme's Board of Directors and serves on the Compensation Committee. The Board determined that she is an independent director within the meaning of the applicable rules of the NASDAQ Stock Market. She is not standing for re-election, and her term expires as of the date of the 2026 Annual Meeting.

Roles

Halozyme Therapeutics, Inc.
Director · Current role
Present
IBM
Vice President, Corporate Development
1998-2011
McKinsey & Company
Senior Advisor
2011-2015
Innosight
Partner
2015-2019

Also at Halozyme Therapeutics, Inc.

Related

See how VectorShift works for your firm

Request Demo